skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 172,671  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: subject: Aged remove subject: Treatment Outcome remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Peginterferon alfa-2a: A review of approved and investigational uses
Peginterferon alfa-2a: A review of approved and investigational uses
Material Type:
Article 		Add to My Research

Peginterferon alfa-2a: A review of approved and investigational uses

Clinical therapeutics, 2004-07, Vol.26 (7), p.991-1025 [Peer Reviewed Journal]

2004 ;2004 INIST-CNRS ;Copyright Elsevier Limited Jul 2004 ;ISSN: 0149-2918 ;EISSN: 1879-114X ;DOI: 10.1016/S0149-2918(04)90173-7 ;PMID: 15336466

Full text available

Citations Cited by
2
Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural‐derived blood exosomes of preclinical Alzheimer's disease
Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural‐derived blood exosomes of preclinical Alzheimer's disease
Material Type:
Article 		Add to My Research

Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural‐derived blood exosomes of preclinical Alzheimer's disease

The FASEB journal, 2015-02, Vol.29 (2), p.589-596 [Peer Reviewed Journal]

FASEB ;FASEB. ;FASEB 2015 FASEB ;ISSN: 0892-6638 ;EISSN: 1530-6860 ;DOI: 10.1096/fj.14-262048 ;PMID: 25342129

Full text available

Citations Cited by
3
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial
Material Type:
Article 		Add to My Research

Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial

Journal of clinical oncology, 2021-04, Vol.39 (11), p.1234-1242 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.20.03282 ;PMID: 33497252

Full text available

Citations Cited by
4
An open label trial of anakinra to prevent respiratory failure in COVID-19
An open label trial of anakinra to prevent respiratory failure in COVID-19
Material Type:
Article 		Add to My Research

An open label trial of anakinra to prevent respiratory failure in COVID-19

eLife, 2021-03, Vol.10 [Peer Reviewed Journal]

2021, Kyriazopoulou et al. ;2021, Kyriazopoulou et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021, Kyriazopoulou et al 2021 Kyriazopoulou et al ;ISSN: 2050-084X ;EISSN: 2050-084X ;DOI: 10.7554/eLife.66125 ;PMID: 33682678

Full text available

Citations Cited by
5
Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device: Results From the PINNACLE FLX Trial
Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device: Results From the PINNACLE FLX Trial
Material Type:
Article 		Add to My Research

Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device: Results From the PINNACLE FLX Trial

Circulation (New York, N.Y.), 2021-05, Vol.143 (18), p.1754-1762 [Peer Reviewed Journal]

ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.120.050117 ;PMID: 33820423

Full text available

Citations Cited by
6
Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
Material Type:
Article 		Add to My Research

Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2117-2124 [Peer Reviewed Journal]

2017 by American Society of Clinical Oncology 2017 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2016.71.6795 ;PMID: 28375787

Full text available

Citations Cited by
7
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50
Material Type:
Article 		Add to My Research

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50

Journal of clinical oncology, 2021-07, Vol.39 (21), p.2339-2349 [Peer Reviewed Journal]

2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.00174 ;PMID: 33872070

Full text available

Citations Cited by
8
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
Material Type:
Article 		Add to My Research

Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer

Journal of clinical oncology, 2017-06, Vol.35 (17), p.1884-1890 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.71.7397 ;PMID: 28296582

Full text available

Citations Cited by
9
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Material Type:
Article 		Add to My Research

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

New England Journal of Medicine, 2021-08, Vol.385 (7), p.585-594 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2108891 ;PMID: 34289274

Digital Resources/Online E-Resources

Citations Cited by
10
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Material Type:
Article 		Add to My Research

Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet, 2020-10, Vol.396 (10259), p.1345-1352 [Peer Reviewed Journal]

2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by/4.0 ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32013-4 ;PMID: 33031764

Digital Resources/Online E-Resources

Citations Cited by
11
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164
Material Type:
Article 		Add to My Research

Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164

Journal of clinical oncology, 2020-01, Vol.38 (1), p.11-19 [Peer Reviewed Journal]

2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.02107 ;PMID: 31725351

Full text available

Citations Cited by
12
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
Material Type:
Article 		Add to My Research

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

Journal of clinical oncology, 2021-06, Vol.39 (18), p.1995-2004 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.03614 ;PMID: 33891478

Full text available

Citations Cited by
13
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
Material Type:
Article 		Add to My Research

Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State

JAMA, 2020-04 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://jamanetwork.com/journals/jama/pages/coronavirus-alert . ;DOI: 10.1001/jama.2020.4326

Digital Resources/Online E-Resources

Citations Cited by
14
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Material Type:
Article 		Add to My Research

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

Journal of clinical oncology, 2018-07, Vol.36 (20), p.2017-2023 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2018.78.8034 ;PMID: 29746227

Full text available

Citations Cited by
15
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study
Material Type:
Article 		Add to My Research

Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study

The American journal of gastroenterology, 2020-05, Vol.115 (5), p.766-773 [Peer Reviewed Journal]

2020 by The American College of Gastroenterology ;2020 by The American College of Gastroenterology 2020 ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/ajg.0000000000000620 ;PMID: 32287140

Full text available

Citations Cited by
16
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer
Material Type:
Article 		Add to My Research

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2018-10, Vol.36 (28), p.2872-2878 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2018.79.0006 ;PMID: 30125216

Full text available

Citations Cited by
17
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic
Material Type:
Article 		Add to My Research

Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic

Annals of oncology, 2020-08, Vol.31 (8), p.1065-1074 [Peer Reviewed Journal]

2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;2020 The Author(s) 2020 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2020.05.009 ;PMID: 32442581

Full text available

Citations Cited by
18
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
Material Type:
Article 		Add to My Research

MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer

Journal of clinical oncology, 2017-11, Vol.35 (32), p.3638-3646 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2017.75.6155 ;PMID: 28968163

Full text available

Citations Cited by
19
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
Material Type:
Article 		Add to My Research

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

Cancer discovery, 2017-06, Vol.7 (6), p.586-595

2017 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-16-1396 ;PMID: 28365644

Full text available

Citations Cited by
20
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Material Type:
Article 		Add to My Research

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

New England Journal of Medicine, 2021-02, Vol.384 (5), p.403-416 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2035389 ;PMID: 33378609

Digital Resources/Online E-Resources

Citations Cited by

Results 1 - 20 of 172,671  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (163,272)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1985  (11)
  2. 1985 To 1995  (3,266)
  3. 1996 To 2004  (27,273)
  4. 2005 To 2014  (85,067)
  5. After 2014  (57,055)
  6. More options open sub menu

Resource Type 

  1. Articles  (172,627)
  2. magazinearticle  (43)
  3. Web Resources  (1)
  4. More options open sub menu

Subject 

  1. Humans  (172,640)
  2. Female  (153,615)
  3. Male  (151,580)
  4. Middle Aged  (146,865)
  5. Adult  (97,377)
  6. Aged, 80 And Over  (60,678)
  7. Retrospective Studies  (51,255)
  8. Biological And Medical Sciences  (48,138)
  9. Medical Sciences  (47,821)
  10. Surgery  (43,765)
  11. Follow-Up Studies  (35,119)
  12. Cardiovascular System & Cardiology  (33,519)
  13. Time Factors  (28,197)
  14. Cardiac & Cardiovascular Systems  (28,093)
  15. Prospective Studies  (26,580)
  16. Adolescent  (26,206)
  17. More options open sub menu

Language 

  1. English  (170,999)
  2. Japanese  (27,421)
  3. Portuguese  (1,555)
  4. German  (1,127)
  5. Spanish  (555)
  6. French  (345)
  7. Russian  (190)
  8. Turkish  (114)
  9. Norwegian  (77)
  10. Polish  (75)
  11. Italian  (73)
  12. Chinese  (65)
  13. Romanian  (62)
  14. Icelandic  (52)
  15. Czech  (29)
  16. Serbian  (28)
  17. Korean  (10)
  18. Lithuanian  (7)
  19. Dutch  (5)
  20. Swedish  (3)
  21. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait